Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

4.74
Delayed Data
As of Jun 23
 +0.15 / +3.27%
Today’s Change
3.34
Today|||52-Week Range
7.15
-22.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Revenue and IncomeNet Revenues0.000.000.0098.0K
 
 
Cost of Goods Sold0.000.000.001.8M
 
 
Depreciation And Amortization41.0K114.0K40.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income-41.0K-114.0K-40.0K-1.7M
 
 
 
 
 
General Expenses36.8M38.4M42.4M61.0M
 
 
 
 
 
Research And Development26.6M24.6M17.2M19.1M
 
 
 
 
 
Total Operating Expenses36.9M38.5M42.4M62.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-36.9M-38.5M-42.4M-62.7M
 
 
 
 
 
Extraordinary Credit0.000.000.00122.0K
 
 
Extraordinary Charge-23.0K-87.0K-14.6M-1.2M
 
 
 
 
 
Interest Expense On Debt1.7M1.7M3.0M790.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-38.6M-40.2M-60.0M-64.6M
 
 
 
 
 
Income Taxes0.000.00-126.0K0.00
 
 
Net Income-38.6M-40.2M-59.9M-64.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS168.1M179.8M190.1M215.5M
 
 
 
 
 
Shares To Calculate EPS Diluted168.1M179.8M190.1M215.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.22-$0.31-$0.30
 
 
 
 
 
EPS Diluted-$0.23-$0.22-$0.31-$0.30